chartexchange

IMNN
Imunon, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:27 PM EST
0.57USD-6.223%(-0.04)75,472
After-hoursNov 18, 2026 4:00:30 PM EST
0.5858USD+2.038%(+0.0117)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Lawrenceville, NJ, USA
Previous Close
$0.61
Beta
0.53
52-Week High
$4.35 2025-12-10
52-Week Low
$0.50 2026-11-12
SMA 50
$1.10
SMA 200
$2.06
Avg. Vol 10D
330,677
Avg. Vol 30D
187,438
Avg. Vol 90D
171,179
Relative Vol
0.40
5.15M
9.9000%
11,909
Aug 7, 2025 · 1-for-1
IMNN Profile

celsion is a biopharmaceutical company dedicated to the research and development of innovative, targeted therapies that address unmet medical needs in oncology. with the recent acquisition of egen, inc., celsion has become a fully integrated company with an extensive, complementary, multi-phase clinical pipeline; platform technologies for the discovery of novel, nucleic acid-based immunotherapies and other anti-cancer dna/rna therapies; and expertise from bench to bedside.

IMNN Performance
PeriodPriceDateChangeBeta
1W0.642026-11-12-8.07%0.896
1M0.992026-10-19-40.57%-0.310
3M1.582026-08-19-62.95%0.223
6M2.232026-05-19-73.75%0.329
1Y3.782025-11-19-84.51%0.528
2Y9.012024-11-19-93.50%—
5Y23.872022-09-21-97.55%0.589
IMNN Stock Summary

Imunon, Inc. Common Stock (NASDAQ:IMNN) stock price today is $0.59, and today's volume is 75,472. IMNN is down 4.378% today. The 30 day average volume is 187,438. IMNN market cap is $3.80M with 6.49M shares outstanding.